27 filings
8-K
FMTX
Forma Therapeutics Holdings Inc
14 Oct 22
Termination of a Material Definitive Agreement
8:48am
8-K
FMTX
Forma Therapeutics Holdings Inc
1 Sep 22
Tender and Support Agreement
8:55am
8-K
FMTX
Forma Therapeutics Holdings Inc
5 Aug 22
Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
7:30am
8-K
FMTX
Forma Therapeutics Holdings Inc
25 Jul 22
Departure of Directors or Certain Officers
4:30pm
8-K
FMTX
Forma Therapeutics Holdings Inc
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
cthf4jehwm9194q11p9
26 May 22
Regulation FD Disclosure
7:30am
8-K
ryb0x0d3ikz2u
6 May 22
Forma Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
7:31am
8-K
jg0 djcsac
1 Mar 22
Forma Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Update
7:31am
8-K
mnq3l
13 Jan 22
Departure of Directors or Certain Officers
7:23am
8-K
hb13 giunwp2pkhmq
16 Dec 21
First Phase 2 combination trial results presented in oral session at 2021 ASH Annual Meeting
7:13am
8-K
qcaeqb pyxf
13 Dec 21
Updated etavopivat Phase 1 trial results presented in two 2021 ASH Annual Meeting Oral Sessions
7:05am
8-K
4j2j3r
12 Nov 21
Forma Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
7:31am
8-K
hs94uuujy84te6tsuz
7 Oct 21
Regulation FD Disclosure
7:32am
8-K
bk8rxozh
13 Aug 21
Forma Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
7:15am
8-K
mku3isn4wqrh1u2x dz
21 Jun 21
Submission of Matters to a Vote of Security Holders
5:04pm
8-K
it0kl1ib
14 Jun 21
Forma Therapeutics Announces Appointment of Industry Veteran John E. Bishop, Ph.D., as Chief Technology Officer
7:12am
8-K
2kg9va
11 Jun 21
Forma Therapeutics Presents New Phase 1 Data on Etavopivat (formerly referred to as FT-4202) at 26th European Hematology Association Congress
7:12am
8-K
oadetkbrlci
14 May 21
Forma Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
7:32am
8-K
yxm16x
30 Mar 21
Forma Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:30am
8-K
ljao9auj
24 Mar 21
Departure of Directors or Certain Officers
4:29pm